Recovery From Psychosis in Schizophrenia - The Impact of Cognitive-Behavioral Therapy
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00791440|
Recruitment Status : Completed
First Posted : November 14, 2008
Last Update Posted : December 13, 2012
|Condition or disease||Intervention/treatment||Phase|
|Schizophrenia Schizoaffective Disorder Schizophreniform Disorder||Behavioral: Cognitive-Behavior Therapy Other: Standard Psychiatric Treatment||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||34 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Psychosis in Schizophrenia: Mechanisms of Recovery|
|Study Start Date :||November 2008|
|Actual Primary Completion Date :||June 2012|
|Actual Study Completion Date :||June 2012|
Up to 26 sessions (over a 30 week period) of weekly, individual Cognitive-Behavior Therapy (CBT) to target hallucinations and delusions in addition to standard psychiatric treatment.
Behavioral: Cognitive-Behavior Therapy
Weekly individual Cognitive-Behavior Therapy (CBT) to target hallucinations and delusions in addition to standard psychiatric treatment.
Other Name: CBT for psychosis
Active Comparator: 2
30 weeks of standard psychiatric treatment.
Other: Standard Psychiatric Treatment
Standard psychiatric treatment.
Other Name: Treatment As Usual (TAU)
- Scale for the Assessment of Positive Symptoms (SAPS) [ Time Frame: At Baseline and after 10, 20 and 30 weeks ]
- Momentary self-report ratings of psychotic symptoms using a Palm computer [ Time Frame: At Baseline and after 30 weeks ]
- Momentary self-report ratings of stress and coping strategies using a Palm computer [ Time Frame: at Baseline and after 30 weeks ]
- Momentary ambulatory measures of heart rate and breathing [ Time Frame: At Baseline and after 30 weeks ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00791440
|United States, New York|
|Columbia University & New York State Psyciatric Institute|
|New York, New York, United States, 10032|
|Principal Investigator:||David Kimhy, Ph.D.||Columbia University & New York State Psyciatric Institute|